Clover Health Investments, Corp. (CLOV) income statement

CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30

$4.88−0.09 (-1.81%)

Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –

Clover Health Investments, Corp. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	1,924	1,371	1,261	1,097	1,472	673	462
Gross Profit	–	–	257	70	-79	–	–
General & Administrative	214	176	183	204	185	121	96
Operating Expenses	2,010	1,417	1,466	1,383	2,109	766	645
Operating Income	-86	-46	-205	-287	-637	-93	-183
Interest Expense	0	0	0.01	1.33	3.19	36	23
Interest & Investment Income	–	–	–	–	–	0.12	–
Merger & Restructuring Charges	0	0.29	9.82	0	0	–	–
Asset Impairment Charges	0	0	4.20	0	0	0	1.63
Gain (Loss) on Investments	0	-0.47	-4.73	9.22	0	0	–
Gain (Loss) on Sale of Assets	–	–	–	–	0	0	-0.02
Pretax Income	-86	-43	-213	–	–	–	–
Income Tax Expense	0	0	0	0	0	0	0
Income from Continuing Operations	-86	-46	-210	-255	–	–	–
Income from Discontinued Operations	0	3.26	-3.21	-85	–	–	–
Net Income incl. Noncontrolling Interests	-86	-43	-213	-340	-588	-136	-364
Net Income	-86	-43	-213	-340	-588	-136	-364
Net Income to Common	–	–	-213	-340	-588	-136	-364
EPS (Basic)(per share)	–	–	-0.44	-0.71	-1.42	-1.54	-4.14
EPS (Diluted)(per share)	–	–	-0.44	-0.71	-1.42	-1.54	-4.14
Shares Outstanding (Basic, Weighted)(shares)	512	490	482	476	413	89	88
Shares Outstanding (Diluted, Weighted)(shares)	512	490	482	476	413	89	88
EBITDA	-87	-48	-209	-288	-637	-93	-186
Premiums Earned	1,892	1,345	1,236	1,085	799	666	457
Net Investment Income	19	23	18	7.54	0.54	2.98	4.54
Policyholder Benefits & Claims	1,568	1,006	1,005	993	1,551	590	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 0.5%
Net margin: 0.5%
Return on equity, FY2025: -26.3%

Financial strength

Current ratio: 1.55
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 77.5%

Valuation

P/E ratio: 488.0
Price to sales: 0.95
Price to book: 6.63
Dividend yield: –

See a number that looks wrong?